These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29194347)

  • 1. In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial.
    Basilico N; Parapini S; Sparatore A; Romeo S; Misiano P; Vivas L; Yardley V; Croft SL; Habluetzel A; Lucantoni L; Renia L; Russell B; Suwanarusk R; Nosten F; Dondio G; Bigogno C; Jabes D; Taramelli D
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29194347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and comparison of antiplasmodial activity of (+), (-) and racemic 7-chloro-4-(N-lupinyl)aminoquinoline.
    Rusconi C; Vaiana N; Casagrande M; Basilico N; Parapini S; Taramelli D; Romeo S; Sparatore A
    Bioorg Med Chem; 2012 Oct; 20(19):5980-5. PubMed ID: 22901673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro.
    Sáenz FE; Mutka T; Udenze K; Oduola AM; Kyle DE
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4685-92. PubMed ID: 22710117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and bioevaluation of novel 4-aminoquinoline-tetrazole derivatives as potent antimalarial agents.
    Pandey S; Agarwal P; Srivastava K; Rajakumar S; Puri SK; Verma P; Saxena JK; Sharma A; Lal J; Chauhan PM
    Eur J Med Chem; 2013 Aug; 66():69-81. PubMed ID: 23792317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-Aminoquinoline derivatives: Synthesis, in vitro and in vivo antiplasmodial activity against chloroquine-resistant parasites.
    Singh S; Agarwal D; Sharma K; Sharma M; Nielsen MA; Alifrangis M; Singh AK; Gupta RD; Awasthi SK
    Eur J Med Chem; 2016 Oct; 122():394-407. PubMed ID: 27394399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum.
    Ridley RG; Hofheinz W; Matile H; Jaquet C; Dorn A; Masciadri R; Jolidon S; Richter WF; Guenzi A; Girometta MA; Urwyler H; Huber W; Thaithong S; Peters W
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1846-54. PubMed ID: 8843292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
    Wirjanata G; Sebayang BF; Chalfein F; Prayoga ; Handayuni I; Noviyanti R; Kenangalem E; Poespoprodjo JR; Burgess SJ; Peyton DH; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5721-6. PubMed ID: 26149984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimalarial activity of novel 4-aminoquinolines active against drug resistant strains.
    Kondaparla S; Soni A; Manhas A; Srivastava K; Puri SK; Katti SB
    Bioorg Chem; 2017 Feb; 70():74-85. PubMed ID: 27908538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Aminoquinoline-ferrocene Hybrids as Potential Antimalarials.
    Nqoro X; Aderibigbe BA
    Recent Pat Antiinfect Drug Discov; 2020; 15(2):157-172. PubMed ID: 32753021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of chiral chloroquine and its analogues as antimalarial agents.
    Sinha M; Dola VR; Soni A; Agarwal P; Srivastava K; Haq W; Puri SK; Katti SB
    Bioorg Med Chem; 2014 Nov; 22(21):5950-60. PubMed ID: 25284252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.
    Le Bihan A; de Kanter R; Angulo-Barturen I; Binkert C; Boss C; Brun R; Brunner R; Buchmann S; Burrows J; Dechering KJ; Delves M; Ewerling S; Ferrer S; Fischli C; Gamo-Benito FJ; Gnädig NF; Heidmann B; Jiménez-Díaz MB; Leroy D; Martínez MS; Meyer S; Moehrle JJ; Ng CL; Noviyanti R; Ruecker A; Sanz LM; Sauerwein RW; Scheurer C; Schleiferboeck S; Sinden R; Snyder C; Straimer J; Wirjanata G; Marfurt J; Price RN; Weller T; Fischli W; Fidock DA; Clozel M; Wittlin S
    PLoS Med; 2016 Oct; 13(10):e1002138. PubMed ID: 27701420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.
    Marfurt J; Chalfein F; Prayoga P; Wabiser F; Kenangalem E; Piera KA; Machunter B; Tjitra E; Anstey NM; Price RN
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4461-4. PubMed ID: 21730116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.
    Marfurt J; Chalfein F; Prayoga P; Wabiser F; Wirjanata G; Sebayang B; Piera KA; Wittlin S; Haynes RK; Möhrle JJ; Anstey NM; Kenangalem E; Price RN
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5258-63. PubMed ID: 22850522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, Docking, In Vitro and In Vivo Antimalarial Activity of Hybrid 4-aminoquinoline-1,3,5-triazine Derivatives Against Wild and Mutant Malaria Parasites.
    Bhat HR; Singh UP; Gahtori P; Ghosh SK; Gogoi K; Prakash A; Singh RK
    Chem Biol Drug Des; 2015 Sep; 86(3):265-71. PubMed ID: 25487527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-Aminoquinoline quinolizidinyl- and quinolizidinylalkyl-derivatives with antimalarial activity.
    Sparatore A; Basilico N; Parapini S; Romeo S; Novelli F; Sparatore F; Taramelli D
    Bioorg Med Chem; 2005 Sep; 13(18):5338-45. PubMed ID: 16054368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antimalarial ferroquine: from bench to clinic.
    Biot C; Nosten F; Fraisse L; Ter-Minassian D; Khalife J; Dive D
    Parasite; 2011 Aug; 18(3):207-14. PubMed ID: 21894260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
    Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
    Sante; 2008; 18(1):43-7. PubMed ID: 18684691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel hybrid molecules based on 15-membered azalide as potential antimalarial agents.
    Starčević K; Pešić D; Toplak A; Landek G; Alihodžić S; Herreros E; Ferrer S; Spaventi R; Perić M
    Eur J Med Chem; 2012 Mar; 49():365-78. PubMed ID: 22321992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro synergistic interaction of potent 4-aminoquinolines in combination with dihydroartemisinin against chloroquine-resistant Plasmodium falciparum.
    Agarwal D; Singh S; Gupta RD; Awasthi SK
    Acta Trop; 2019 Nov; 199():105109. PubMed ID: 31351071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable Preclinical Pharmacological Profile of a Novel Antimalarial Pyrrolizidinylmethyl Derivative of 4-amino-7-chloroquinoline with Potent In Vitro and In Vivo Activities.
    Basilico N; Parapini S; D'Alessandro S; Misiano P; Romeo S; Dondio G; Yardley V; Vivas L; Nasser S; Rénia L; Russell BM; Suwanarusk R; Nosten F; Sparatore A; Taramelli D
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.